- Todos > Medicine Access and Rational Use > Supply Management
- Todos > Diagnostics and Laboratory Technology > Evaluation of Diagnostics
- Palabras clave > good quality in vitro diagnostics (IVDs)
- Palabras clave > post-emergency-use-listing safety monitoring - medicines, IVDs, vaccines granted EUAL
- Palabras clave > procurement - HIV and HIV-related in vitro diagnostics, laboratory items and equipment
- Palabras clave > selection process
- Palabras clave > in vitro Diagnostic (IVD)
- Palabras clave > in vitro diagnostic medical devices
- Palabras clave > WHO Model List of Essential In Vitro Diagnostics (EDL)
(2018; 48 pages) [French]
This publication aims to provide information on procurement processes specific to HIV and HIV-related in vitro diagnostics, laboratory items and equipment. This guidance is not intended to replace existing guidelines on basic procurement processes but rather to enhance and extend current processes to include specific issues related to diagnostics and related items/equipment that are considered essential to ensure high quality testing services.
The intended audience are WHO Member States including programme managers, end-users, procurement officers; staff in United Nations (UN) agencies; and non-governmental organizations (NGOs) who conduct the selection and use of in vitro diagnostics and related laboratory items and equipment.
Users of this guidance who procure with financial resources from multilateral or bilateral agencies or sources other than national funds will be obliged to follow the rules, regulations and policies of the funding organization. As such there may be certain guidance that is different to the guidance set down in this document.
Finally, the country programmes themselves should be the ultimate decision makers for procurement decisions.